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In contrast for 10 prevention with full efficacy over 10 years, the incremental
C/E is $33,500 per YOLS for men and $35,500 for women. With the full ben-
efit suggested by the epidemiologic studies, the potential years of life saved
in the US from treatment with vit E are:
NoCP
IND N-IND
473 169 642
130 203 333
603 372 975
x2 ~ 110, P < 00001
Central Hemodynamic and Gas Exchange
Adaptlons to Training in Chronic Heart Failure
IND N-IND
All Patients
649 369 1018
269 615 884
918 984 1902
x2 = 209, P< 00001
The Cost and Appropriateness of Radionucllde
Exercise Stress Testing by Cardiologists and
Non-cardiologists
James H. Stein, Eugene F. Uretz, Joseph E. Parrillo, John 1. Barron. Rush Medical
Co/lege, Chicago. IL
CARD
N-CARD
It is generally accepted that a patient with a normal baseline electrocardio-
gram (ECG) should undergo exercise stress testing (EST) to establish the
diagnosis and prognosis of coronary artery disease (CAD), unless standard
EST exclusion criteria are present. Initial evaluation with radionuclide EST
(REST) is an unproven approach that is approximately three times more ex-
pensive than EST alone. The appropriateness and financial ramifications of
REST at an urban university hospital were evaluated during a fourteen month
period.
Patients with clear indications for REST - previously positive EST, prior
myocardial infarction, or previous percutaneous transluminal coronary angio-
plasty - were excluded. REST studies were performed for the diagnosis or
management of CAD in 1902 patients, of whom 975 did not have chest pain.
If the baseline ECG was normal and standard EST exclusion criteria (mitral
valve prolapse, bundle-branch block, significant ST-segment deviation) were
not present, REST was considered not indicated (N-INDI.
EXERCISE PHYSIOLOGY AND TESTING
Non-eardiologists (N-CARD) were more likely than cardiologists (CARD) to
order REST studies in patients without indications for isotopes. Assuming an
excess charge of $11 00 per patient, an unnecessary $1,082,400 was billed in
this population, $409.200 of which was for patients who did not have chest
pain. Assuming a charge of $175 per patient, referral to a cardiologist prior
to REST would have saved $185,260 in this population.
In conclusion, non-cardiologists are more likely to inappropriately order
REST studies than are cardiologists, at a significant excess cost. Although
cardiologists also over utilize REST studies, referral to a cardiologist prior to
testing for CAD may be cost-effective.
treadmill testing (all of which were normal); systolic BP > 170 or diastolic
BP > 110 (n = 5). carotid bruit In = 21, severe AI by exam (n = 1). WPW (n
= 6). PVC's (n = 5). RBBB (n = 4), SVT (n = 1). EKG alone led to disqualifi-
cation in 16 or 1/350 HSA undergoing screening. No cases of hypertrophic
cardiomyopathy or anomalous coronary artery were detected prospectively.
One SCD occurred in an approved HSA due to anomalous coronary artery.
Conclusions: Common causes of SCD in HSA are rare and/or methods to
detect them are insensitive; serious CU abnormalities in this population are
rare; EKG added to the cardiovascular history and physical exam increases
the ability to detect potentially serious abnormalities necessitating further
cardiovascular testing before approval for competitive sports.
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Background. Exercise Training has just recently been recognized as an impor-
tant therapeutic modality in patients with chronic heart failure (CHF). How-
ever, central hemodynamic adaptations to exercise training in patients with
CHF remain unclear.
Methods. Seventeen patients with first diagnosis of CHF (56 ± 5 years,
mean EF ~ 32 ± 6%) were randomized to an exercise raining group (N =
8), or a control group (N = 9). Patients in the exercise group performed two
hours of daily walking along with five sessions per week of high intensity
monitored stationary cycling (40 minutes at 70 to 80% peak capacity) at
a residential rehabilitation center for a period of two months. Control pa-
tients received usual community care. Ventilatory gas exchange and upright
hemodynamic measurements (rest and peak exercise cardiac output, pul-
monary artery, wedge, and mean arterial pressures, and systemic vascular
resistance) were performed before and after the study period.
Results. Changes in oxygen uptake at maximal exercise and the lactate
threshold (LT) were as follows:
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YOLS in 20 prevention
YOLS in 10 prevention
Group Follow-up Actuarial Survival (%)
(months) 5 yrs 10 yrs 15 yrs
LBBB 112 110 ± 67 96 88 81
LBBB Control 112 125 ± 69 99 92 92
RBBB 198 113 ± 71 98 95 90
RBBB Control 198 119 ± 72 99 94 90
The Natural History of Isolated Bundle Branch
Block: Results from a Population Screened Over
a Quarter Century
Gerard J. Fahy, Sergio L. Pinski, Dave P. Miller, Noeleen McCabe, Carol Pye,
Michael J. Walsh, Killian Robinson. The Irish Heart Foundation, DUblin, Ireland; The
Cleveland Clinic Foundation. Cleveland, Ohio
Prospective Screening of 5615 High School
Athletes for Sudden Cardiac Death
Colin M. Fuller, Donald A. Spring, Kosta M. Arger, Stephen A. Bruce, Eric
M. Drummer, Frank P. Kelley, Michael J. Newmark, Gerald H. Whipple. Sierra Heart
Institute and the University ofNevada Medical School, Reno, Nevada
Screening for common causes (hypertrophic cardiomyopathy and anoma-
lous coronary artery) of sudden cardiac death (SCD) in high school athletes
(HSA) during pre-participation exams is varied and relatively unstudied. Ef-
forts to improve diagnoses of potentially serious or lethal congenital heart
conditions are needed. We prospectively evaluated HSA at 34 different high
schools over three years. Cardiovascular screening included obtaining a his-
tory of angina or anginal equivalents, or a family history of SCD before age 35
years. A 12-lead EKG and a cardiovascular physical exam were performed.
Abnormalities resulted in a cardiac ultrasound (CU). Abnormal EKG for LVH
was defined in boys as SVl and RV5 > 50 mm and in girls as SVl plus RV5 >
40 mm. Follow-up of cardiovascular abnormalities followed 16th Bethesda
Conference Guidelines. Results: 5.615 HSA (3378 boys, 2237 girls) were eval-
uated. 115 (2%) had abnormal cardiovascular history, 196 (3.5%) had abnor-
mal cardiovascular exam, 193 (3.5%) had abnormal EKG and 126 (2%) had
combined abnormalities. All 630 (11 %) with abnormal cardiovascular screen-
ing underwent CU at the time of their exam. 43 HSA (7% of CU performed)
were found to have minor abnormalities. No serious previously undetected
abnormality was noted with CU. No LVH was seen in 28 HSA with LVH by
ECG. 5140 (91.5%) HSA were approved for competitive sports; 435 (7.8%1
HSA were approved for competitive sports after follow-up by local M.D. (rec-
ommended primarily for evaluation of mild hypertension); 40 (0.7%) HSA
were not approved due to anginal symptoms (n = 16) requiring subsequent
Background and Methods. The prognostic implications of the incidental dis-
covery of LBBB or RBBB in people without clinically apparent heart disease
remain uncertain. We compared the outcome of 310 such people identified
during screening carried out by The Irish Heart Foundation between 1968
and 1993, and 310 similarly screened age- and sex-matched controls with
similar cardiovascular risk factor profiles.
Results. Persons with isolated LBBB and RBBB constituted 0.1 % and
0.18% respectively, of the screened population After similar follow-up peri-
ods, total actuarial survival (Kaplan-Meier method) was no different for those
with RBBB, LBBB and their respective controls (see table).
Cardiac mortality, however, was increased in the LBBB, but not RBBB,
group when compared to their respective controls (p = 0.01, log-rank test).
At follow-up, overt cardiac disease was evident in 21 % of those with LBBB
compared to 11 % of their controls (p = 0.04). No such difference was ob-
served for those with RBBB.
Conclusions. 1. Isolated LBBB, but not RBBB is associated with an in-
creased long-term cardiac, but not total mortality. 2. Isolated LBBB is a
marker for the subsequent development of clinically overt cardiac disease.
This analysis suggests: 1) For 20 prevention, vit E is worthwhile even if it
causes a 5% or less reduction in CHD. 2) At the above cost over 10 years,
widespread 10 prevention with vit E would be cost-effective only if Vit E is
about as effective as suggested by the cohort studies. 3) If vit E is as effective
as suggested by the above studies (or even 1/8th that for 2' prevention).
then the potential loss of benefit by delaying its use is sufficiently large that
research into the efficacy of Vit E should be a high priority.
1901-671
1901-68\
Exercise
Exercise group Control group
PRE POST PRE POST
V02 max Iml/kg/min) 19.6 ± 3 24.9 ± 3* 19.6 ±4 19.3 ± 5
V02 LT Iml/kg/min) 130 ± 3 17.8 ± 2* 12.3 ± 2 12.0 ± 2
Geographic Variation in the Utilization of
Pacemaker Technology
0-64 65+
NTL In = 732) Epi In = 806) NTL(n = 624) Epi In ~ 665)
Male 80% 83% 84% 86%
CAD 65% 71% 89% 84%
Hx CA 49% 45% 41% 42%
Medn EF 0.36 0.33 032 032
NYHA III or IV 15% 17% 19% 19%
Survival at l-yr 95% 90% 90% 85%
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The goal of this study was to identify differences in perea pita rates of single
and dual-chamber pacemaker implantation and rates of implantation for a
given conduction disorder at the county level in the State of California. Sig-
nificant geographic variation has been documented in the use of coronary
angiography and coronary artery bypass surgery. We used a large database,
the California Discharge Database, during the years 1984-1992 to identify
the diagnostic codes of patients at risk (complete heart block, Mobitz II block,
sinoatrial dysfunction, and other heart block) for a single or dual-chambered
pacemaker in the twelve most populous counties. Rates were calculated by
identifying patients from a given county who received a pacemaker and di-
viding by the county population in age groups '65-80' and 'over 80', while
controlling for a given diagnostic code. These aged groups captured 79%
of all implants IN ~ 2827 in 1984). Implantation rates per diagnosis were
also calculated for a given county. There was variability in implantation rates
among large counties in California with greater than 100 pacemaker implants
in 1984 and 1985. The overall (ventricular + atrioventricular) rate, by county,
was significantly different in the population groups '65-80' (p < 0.005) and
'over 80' (p < 0.0005). If atrial pacemakers were included in the analysis, the
differences in rates persisted; '65-80' (p < 0.005) and 'over 80' (p < 0.002).
For dual chamber implants only there also was significant variability in both
the 65-80 and >80 aged groups (p < 0.00011 among counties. There also
was significant variability in the ratio of dual to single-chamber pacemakers
by county in both age groups (p < 0.0005).
Conclusion: Initial data using a comprehensive database has identified ge-
ographic variability in county rates of pacemaker implantation independent
of diagnosis. This geographic variation in utilization may represent physician
uncertainty in the use of pacemaker technology.
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The improved observed survival with NTL vs. Epi ICDs was significant in
both the 0-64 (p < 0.0001) and the 65+ (p = 0.001) age groups. Even af-
ter adjustment for differences in pt characteristics, and cardiovascular or ar-
rhythmia descriptors, the risk of death was still lower in NTL pts for both
0-64 (p < 0.0001) and 65+ (p = 0.02).
Conclusions; 1) Pts 2: 65 yrs of age benefit as much as younger pts
from NTL devices. 2) At a time when only Epi-type ICD systems were FDA-
approved, preventing access to investigational (and less invasive) NTL device
systems would have denied older pts a greater 1-yr survival compared to that
achievable with an Epi ICD. 3) These results suggest that relevant medical
data should be availableto policy makers and the public to facilitate informed
decisions regarding third-party payment for investigational devices.
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Repeated Exercise Induced Ischemia Causes
Myocardial Preconditioning
Simon Maybaum, Michaeillan, Jacob Mogilevsky, Dan Tzivoni. Jesselson Heart
Center, Sheare Zedek Medical Center, Jerusalem, Israel
2 3 1 vs 2 1vs 3
Time to 1 mm (sec) 487 593 572 0004 0021
Recovery Time (sec) 259 126 109 00001 000002
Total Ischemic Time Isec) 633 399 430 00001 0002
Double Product at 1 mm 20322 22325 21298 0008 0.163
Exercise Duration (sec) 862 864 885 0887 0.235
*p < 0,5 within and between groups
The increase in V02 max in the trained group paralleled an increase in
maximal cardiac output (11.8 pre vs. 12.8 I/min post p < 0.051, but maximal
cardiac output did not change in controls. None of the hemodynamic pres-
sures at rest or during exercise differed within or between groups. All of the
increase in V02 max occurred during the first month of training, whereas sig-
nificant increases in V02 LT were observed after both months. Both blood
lactate and perceived exertion levels were significantly lower at matched
ramp work rates after raining.
Conclusion. Training benefits occur early in the course of rehabilitation in
CHF and are mediated through increases in maximal cardiac output, but not
central hemodynamic status. Training longer than one month after the onset
of CHF does not increase V02 max further, but may provide further increases
in V02 LT.
Repeated short episodes of coronary occlusion in experimental animals
cause myocardial preconditioning which reduces the extent of further is-
chemia. The purpose of the present study was to assess whether precondi-
tioning also occurs during repeated exercise induced ischemia.
Twenty-six coronary patients with positive exercise tests had 3 treadmill
exercise tests at 30 minutes intervals. Two additional stress tests were per-
formed on each of the previous 2 days, in order to eliminatelreduce the tra in-
ing effect The 1st exercise test was regarded as baseline, while the 2nd (ex-
21 and 3rd (ex-3) were compared to the 1st. Time to 1 mm ST depression
(STD). recovery time (from maximal ischemia to 1 mm STD). total ischemic
time (from 1 mm STD during exercise to regression of ischemia to 1 mml,
double product at 1 mm STD and exercise duration were assessed.
Preconditioning (defined as an improvement of 10% or more) was seen in
2 or more parameters in 76% of the patients.
These data indicate that total ischemic time and recovery time were
markedly reduced and that time to 1 mm STD was prolonged and the double
product at 1 mm of STD (ischemic threshold) was higher in the second exer-
cise. This is the first evidence that myocardial preconditioning occurs during
repeated exercise induced ischemia.
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[901-721 Potential Survival Benefit from Investigational
Devices in Patients >65 Yrs: Lessons from the
Implantable Cardioverter Defibrillator (ICD)
Experience
Michael H. Lehmann, Diana Roberts, Timothy R. Church, PCD Investigators. Sinai
Hospital, Detroit, MI; Medtronic, Inc., Minneapolis, MN
Controversy regarding the issue of Medicare reimbursement for investiga-
tional devices led us to examine the medical implications of this debate. Pt
survival was estimated in a large ICD ("PCD"I clinical investigation spanning
the transition from epicardial (Epi) systems to the less invasive nonthoraco-
tomy lead (NTLI systems (5/89-1/931, a period during which only Epi-type
devices were FDA-approved. Among the 1471 Epi and 1356 NTL implanta-
tions, 1289 (46%) of system recipients were 2:65 yrs of age ("65+") and the
remainder were under age 65 ("0-64"). Cumulative survival at 1-yr was an-
alyzed within age groups, controlling for clinical descriptors (where CAD =
coronary artery disease; CA ~ cardiac arrest; and NYHA = NY Heart Asso-
ciation Functional Class):
Delayed and Incomplete Reversal of Impaired
Metabolic Vasodilation in Patients with Heart
Failure During Long-term Circulatory Support
with a Left Ventricular Assist Device
Stuart D. Katz, Howard Levin, Milton Packer. Columbia University College of
Physicians & Surgeons, New York, NY
Impaired vasodilation in response to metabolic stimuli in the peripheral cir-
culation is an important determinant of exercise intolerance in patients with
congestive heart failure (CHF). The pathogenesis of impaired metabolic va-
sodilation in patients with CHF is uncertain but may be related in part to
chronic reductions in peripheral blood flow in patients with low cardiac out-
put (CO). A left ventricular assist device (LVADI is an implantable mechanical
pump that provides a non-pharmacologic means to markedly Increase CO In
patients with severe CHF for long periods of time. Whether long-term me-
chanical restoration of normal resting CO with an LVAD enhances metabolic
vasodilation in the peripheral circulation of patients with CHF is unknown.
Accordingly, peak forearm blood flow (FBF, mllminll00 ml) after 5 minutes
of brachial artery occlusion (a maximal metabolic vasodilation stimulus) was
measured with venous occlusion plethysmography in 8 patients with NYHA
Class IV CHF (mean age 52 yrs, mean EF 22%) before, and 1 and 8 weeks
(wks) after continuous LVAD support and in 8 normal subjects. Mean arterial
